RedHill Biopharma reported $5.51M in Operating Expenses for its fiscal quarter ending in June of 2024.





Operating Expenses Change Date
Cara Therapeutics USD 7.05M 1.11M Mar/2026
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 11.44M 246K Jun/2026
Cronos Group USD -33.51M 78.92M Sep/2026
RedHill Biopharma USD 5.51M 1.08M Jun/2024